Trade AGMB stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
AgomAb Therapeutics NV American Depositary Shares (AGMB) is trading at US$12.17, up 0.75% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$652.54M. Over the past 52 weeks, AGMB has traded between US$8.75 and US$17.82. On Syfe you can trade AGMB with $0 commission and add it to your watchlist.
| Previous close | US$12.08 |
|---|---|
| Market cap | US$652.54M |
| 52-week range | US$8.75 – US$17.82 |
| Volume | 250.62K |
| Exchange | US |
Add to Watchlist
Set Price Alert
AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases. Its mission is to develop disease-modifying therapeutics that aim to resolve fibrosis and restore organ function, enabling patients with these disorders to live fuller and healthier lives. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium.
Year: 2026
Cantor Fitzgerald Initiates AgomAb Therapeutics at Overweight
Aug 19, 10:47 AM · MT Newswires
B. Riley Initiates AgomAb Therapeutics at Buy With $34 Price Target
Jul 23, 12:22 PM · MT Newswires
Agomab Therapeutics Shares NOV-ERA Phase 2b Study Design With Ontunisertib in Fibrostenosing Crohn's Disease
Jun 23, 9:32 PM · MT Newswires
--HC Wainwright Initiates AgomAb Therapeutics at Buy With $35 Price Target
Jun 22, 10:10 AM · MT Newswires
AgomAb Says Investigational Fibrosis Drug AGMB-447 Receives US Patent
Mar 26, 11:25 AM · MT Newswires
Stay on top of AGMB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
